The Serum Institute will invest $300 million in Biocon’s unit

The Serum Institute will invest $300 million in Biocon’s unit.

A division of the Serum Institute of India, the largest manufacturer of vaccines worldwide.

[{"selector":"#anim-9bb71f18-60cd-4c2d-a2f1-7b4e41eb54ca [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-21.428571729678545%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Serum Institute of India, the largest manufacturer of vaccines in the world.

[{"selector":"#anim-2db7e221-50cd-422e-a441-c872000e15b6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-24.928571064573624%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Four investors in the style of private equity have previously invested in Biocon Biologics.

[{"selector":"#anim-731941b4-5c1f-46d2-ac1b-565a23f1b5ff [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-24.928571064573624%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]